高度差异化甲状腺癌的诊断挑战,预后评估和治疗策略
Chan Kwon Jung1,2, Agnes Stephanie Harahap3
1Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Endocrinology and metabolism (Seoul, Korea)
|December 11, 2025
概括
高度差异化甲状腺癌 (HGDTC),一个新的世卫组织分类,提出了诊断挑战. 本综述有助于识别HGDTC,了解其分子方面,并优化患者管理.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 高度差异化甲状腺癌 (HGDTC) 是2022年世卫组织内分泌瘤分类中的一个新实体.
- 在差异化甲状腺癌中,HGDTC是由特定的组织病理学标准定义的,包括线粒细胞计数和瘤缩.
研究的目的:
- 审查HGDTC的组织病理识别,分子特征和预后决定因素.
- 总结HGDTC不断发展的治疗模式.
- 为HGDTC提供有关诊断陷和管理策略的指导.
主要方法:
- 关于HGDTC的当前证据的文献综述.
- 对诊断标准和陷的分析.
- 对分子特征和预后因素的评估.
- 综合不断发展的治疗策略.
主要成果:
- HGDTC需要仔细地对其组织病理学评估,以区分其与其他甲状腺癌.
- 特定的模式,如高度乳头甲状腺癌和扩散性硬化亚型等需要注意.
- 侵袭表型显著影响预后.
- 亚厘米瘤单独增加了线粒分裂,不应该被过度诊断为HGDTC.
结论:
- 一个综合的,逐步的诊断方法对于HGDTC至关重要.
- 准确的风险分层和多学科管理对于优化患者的治疗结果至关重要.
- 对HGDTC分子驱动因素和向疗法的进一步研究是有必要的.
相关概念视频
Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...


